Therapy Activation Specialist TMTT-EVOQUE (device specialist; Germany - north/north-east)

Transcatheter Mitral & Tricuspid Therapies (TMTTs) are the future of Edwards – Estimated to be a more than $5 billion opportunity by 2028, Edwards will discuss its multiple transcatheter programs aimed at transforming care for the many patients suffering from mitral and tricuspid regurgitation. Since 2017 Edwards launched already multiple products – transformational therapies in Europe led by its CARDIOBAND, PASCAL and EVOQUE programs. We are already developing another therapy, expecting CE mark in 2025. Requested candidate locations: Germany - north / northeast regions preferred:Schleswig-Holstein, Mecklenburg-Vorpommern, Berlin, Brandenburg, Lower Saxony, Saxony-Anhalt, Saxony, Thuringia. Travelling in Germany and EU will be requested. Therapy Activation Specialist EVOQUE is responsible for the delivery of TMTT educational curriculum and practical onboarding of Health Care Professionals (HCPs; Physicians) within the field. To accelerate new account certification and learning curve in support of site opening and physician training will be your key duty. Providing feedback to PEMA leadership commitment & competence of HCP´s and support

---